Summaries & Highlights
ecancer
ESMO 2024 Summary: Key Trial Insights on Managing NSCLC With Low PD-L1 Expression
FEATURING
Luis Paz-Ares
- 221 views
- February 3, 2025
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO Asia 2024 Summary: mUC Key Trial Analysis - KEYNOTE-A39, CheckMate 901, SPADE, and TROPiCS-04
FEATURING
Terence Friedlander
- 62 views
- December 17, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Long-Term Survival Outcomes in Advanced Melanoma - Insights From CheckMate 067, KEYNOTE-006, and ImmunoCobiVem Trials
FEATURING
Jessica Hassel
- 53 views
- November 6, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Optimal Sequencing of Therapeutic Strategies in Immunogenic mCRC
FEATURING
Thierry André
- 63 views
- November 5, 2024
2024 ESMO Annual Meeting Insights Hub
Sequencing CRC Targeted Therapies Based on Biomarkers and Biology
FEATURING
Lukas Weiss
- 88 views
- November 4, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Developmental Therapeutics Highlights
FEATURING
Guru Sonpavde
- 327 views
- October 25, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: mBC Panel Discussion on Key Studies - DESTINY-Breast12, CAPItello-290, and ICARUS-BREAST01
FEATURING
Sara Tolaney,
Hope Rugo
- 583 views
- October 4, 2024
- 7
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Advances, Wins, and Challenges
FEATURING
Mansoor Raza Mirza
- 446 views
- September 20, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in HCC
FEATURING
Richard Kim,
Tiago Biachi
- 284 views
- October 21, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Latest Advances in Targeted Therapies for Pancreatic Cancer
FEATURING
Davide Melisi
- 292 views
- October 17, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Systemic Treatment for ILCs in Breast Cancer
FEATURING
Jens Huober
- 373 views
- October 17, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: eBC Panel Discussion on Key Studies - KEYNOTE-522, I-SPY 2.2, and NATALEE
FEATURING
Sara Tolaney,
Hope Rugo
- 658 views
- October 4, 2024
- 5
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Practice-Shaping Prostate Cancer Trials
FEATURING
Eleni Efstathiou
- 153 views
- October 15, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Updates in Pancreatic Cancer and Impacts on Practice
FEATURING
Hani Babiker
- 434 views
- October 14, 2024
- 5
ecancer
ESMO 2024 Insights: ROME Basket Trial - Targeting Actionable Mutations vs. SoC in Pts With Advanced Solid Tumors
FEATURING
Andrea Botticelli
- 19 views
- October 22, 2024
ecancer
ESMO 2024 Summary: Highlights & Analysis of the Biggest Solid Cancer Updates
FEATURING
Bishal Gyawali
- 49 views
- October 21, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-Breast12, KEYNOTE-522, CAPItello-290 & ICARUS-Breast01
FEATURING
Paolo Tarantino
- 1,567 views
- September 24, 2024
- 6
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in CRC and Impacts on Practice
FEATURING
Richard Kim,
Tiago Biachi
- 300 views
- October 21, 2024
- 5
ecancer
ESMO 2024: Optimizing the Personalization of Prostate Cancer Treatment
- 51 views
- October 22, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Updates in HCC and Impacts on Practice
FEATURING
Hani Babiker
- 222 views
- October 14, 2024
- 2
ecancer
ESMO 2024 Summary: Understanding the Use of PARPi Combinations to Treat Patients With mCRPC
- 25 views
- October 11, 2024
ecancer
ESMO 2024 Summary: EGFRm NSCLC Panel Discussion - MARIPOSA, PAPILLON, REZILIENT1, LAURA, and SKIPPirr
- 375 views
- October 11, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mCRPC) and NIAGARA (MIBC)
FEATURING
Robert Dreicer
- 395 views
- September 24, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in Heme Malignancies
FEATURING
Maria Gomes da Silva
- 581 views
- September 23, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunotherapy in Unresectable HCC
FEATURING
Lorenza Rimassa
- 539 views
- September 20, 2024
- 8
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Practice-Changing Trials for Patients With Localized MIBC - NIAGARA and AMBASSADOR
FEATURING
Petros Grivas
- 316 views
- September 20, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Head & Neck Cancer Highlights
FEATURING
Nabil Saba
- 401 views
- September 23, 2024
- 5
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Bladder and RCC Highlights
FEATURING
Karine Tawagi,
Natalie Reizine
- 120 views
- October 10, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights of Radioligand Therapies in Prostate Cancer
FEATURING
Natalie Reizine,
Karine Tawagi
- 139 views
- October 10, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients With Bone Metastases
FEATURING
Robbe Van den Begin
- 764 views
- September 26, 2024
- 8
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights of Important Trials in Sarcoma
FEATURING
Robin Jones
- 257 views
- October 9, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Neoadjuvant Immunotherapy as the Future of Melanoma Treatment - Identifying Patients Who Need Surgery
FEATURING
Alexander van Akkooi
- 74 views
- October 9, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Novel Agents and Promising Combinations in mRCC and mUC
FEATURING
Begoña Pérez-Valderrama
- 128 views
- October 8, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Managing Durable Responses and De-Escalation Strategies in Urothelial Cancer With Systemic Therapy
FEATURING
Debbie Robbrecht
- 26 views
- October 8, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Tailoring Therapy in TNBC and Beyond
FEATURING
Lisa Carey
- 381 views
- October 8, 2024
- 5
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Updates in the Treatment of MCL
FEATURING
Georg Hess
- 305 views
- September 27, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Antibody Drug Conjugates (ADCs) - Identifying New Therapeutic Approaches in Gynecologic Cancers
FEATURING
Susana Banerjee
- 121 views
- October 8, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Head & Neck Cancer Take Home Messages
FEATURING
Paolo Bossi
- 496 views
- October 8, 2024
- 7
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Discussing Key Studies on the Use of Zipalertinib, Zidesamtinib, and PM8002/BNT327 With CT in NSCLC
FEATURING
Joop Langen
- 80 views
- October 7, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Optimizing Precision Therapy in HR+/HER2- Advanced Breast Cancer Post-Endocrine + CDK4/6i
FEATURING
Philippe Aftimos
- 204 views
- October 7, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Liquid Biopsies in GI Cancers - Learnings From Colorectal Cancer
FEATURING
Naureen Starling
- 196 views
- October 7, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clinical and Translational Advances
FEATURING
Julien Taieb
- 420 views
- October 6, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: Predicting the Outcomes of Advanced Cutaneous Melanoma Cases Following Discontinuation of Immune Checkpoint Inhibition
FEATURING
Ka-Won Noh,
Oana Diana Persa
- 78 views
- October 3, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Optimizing Curative Opportunities in Early HCC
FEATURING
Stephen L. Chan
- 115 views
- October 2, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Important GU Trials - ETER100 (RCC), TACITO (mRCC), and CheckMate 9ER (aRCC)
FEATURING
Camillo Porta
- 240 views
- October 2, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Evaluation of Ivonescimab + CT and PM8002/BNT327 + Nab-Paclitaxel for 1L TNBC: Results From Two Studies
FEATURING
Carmen Criscitiello
- 176 views
- October 1, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Metastatic Melanoma Highlights
FEATURING
Christian Blank
- 260 views
- September 25, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose
FEATURING
Howard Hochster
- 618 views
- September 23, 2024
- 6
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Important GU Trials - EV-103 5-Year Follow-Up (la/mUC), NIAGARA (MIBC), and Other Updates
FEATURING
Elizabeth R. Plimack
- 232 views
- September 27, 2024
- 4
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in mBC
FEATURING
Giampaolo Bianchini
- 739 views
- October 1, 2024
- 8
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Breast Cancer Highlights - AURORA Program, DAISY Trial, DESTINY-Breast06 Study, and Targeted Therapy Sequencing
FEATURING
Christos Sotiriou
- 745 views
- October 1, 2024
- 5
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: IDH Mutated AML - Diagnostic and Treatment Paradigm
FEATURING
Teresa Macarulla Mercade
- 59 views
- September 30, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: IDH Mutated Cholangiocarcinoma - Diagnostic and Treatment Paradigm
FEATURING
Teresa Macarulla Mercade
- 50 views
- September 30, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Primary CNS Lymphoma - Updated ESMO and EHA Guidelines
FEATURING
Andres Ferreri
- 122 views
- September 30, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: ctDNA and Molecular Screening for Target Detection and Treatment Monitoring in mBC
FEATURING
Michail Ignatiadis
- 173 views
- September 26, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Breast Cancer Highlights - KEYNOTE-522, NATALEE, DESTINY-BREAST12, and CAPItello-290
FEATURING
Virginia Kaklamani
- 690 views
- September 23, 2024
- 7
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Key Trial Results in Advanced Bladder Cancer Treatment
FEATURING
Guru Sonpavde
- 169 views
- September 24, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Advances in Cervical Cancer Management - Comprehensive Strategies for Recurrent or Metastatic Disease
FEATURING
Domenica Lorusso
- 233 views
- September 23, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials
FEATURING
Douglas Johnson
- 229 views
- September 25, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: The Latest Data on NMIBC and Localized MIBC
FEATURING
Félix Guerrero-Ramos
- 57 views
- September 25, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Bladder Cancer Highlights - JCOG1019, TOMBOLA, and SunRISe-4
FEATURING
Bogdana Schmidt
- 132 views
- September 23, 2024
- 2